Shopping Cart
Remove All
Your shopping cart is currently empty
Etalocib sodium
Copy Product Info
😃Good
Catalog No. T201014Cas No. 152608-41-8
Alias LY293111 sodium
Etalocib (LY293111) sodium is an orally active leukotriene B4 (LTB4) receptor antagonist with a Ki value of 25 nM for inhibiting [3H]LTB4 binding. It exhibits an IC50 of 20 nM against LTB4-induced calcium mobilization. Additionally, Etalocib sodium can induce apoptosis.
Etalocib sodium
Copy Product Info😃Good
Catalog No. T201014Alias LY293111 sodiumCas No. 152608-41-8
Etalocib (LY293111) sodium is an orally active leukotriene B4 (LTB4) receptor antagonist with a Ki value of 25 nM for inhibiting [3H]LTB4 binding. It exhibits an IC50 of 20 nM against LTB4-induced calcium mobilization. Additionally, Etalocib sodium can induce apoptosis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,270 | 3-6 months | 3-6 months | |
| 50 mg | $2,980 | 3-6 months | 3-6 months | |
| 100 mg | $4,000 | 3-6 months | 3-6 months |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Etalocib (LY293111) sodium is an orally active leukotriene B4 (LTB4) receptor antagonist with a Ki value of 25 nM for inhibiting [3H]LTB4 binding. It exhibits an IC50 of 20 nM against LTB4-induced calcium mobilization. Additionally, Etalocib sodium can induce apoptosis. |
| In vitro | Etalocib sodium exhibits concentration-dependent inhibition of LTB4-induced upregulation of CD11b. It acts as an extremely potent and selective antagonist of human neutrophil functions in vitro. Additionally, at concentrations of 250 and 500 nM over 24-72 hours, Etalocib sodium induces apoptosis and inhibits proliferation in human pancreatic cancer cells. |
| In vivo | Etalocib demonstrates dose-dependent attenuation of acute leukotriene B4-induced airway obstruction, with an (ED 50 =14 μg/kg) when given intravenously and an (ED 50 =0.4 mg/kg) when administered orally. At a dosage of 10 mg/kg, it reduces lung inflammation induced by A23187 within one hour. Furthermore, daily oral administration of Etalocib at 250 mg/kg effectively suppresses the growth of human pancreatic cancer xenografts in athymic mice. |
| Synonyms | LY293111 sodium |
| Molecular Weight | 566.59 |
| Formula | C33H32FNaO6 |
| Cas No. | 152608-41-8 |
| Smiles | O=C(C1=C(OC2=CC=CC(OCCCOC3=C(CC)C=C(C4=CC=C(F)C=C4)C(O)=C3)=C2CCC)C=CC=C1)[O-].[Na+] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Etalocib sodium | purchase Etalocib sodium | Etalocib sodium cost | order Etalocib sodium | Etalocib sodium chemical structure | Etalocib sodium in vivo | Etalocib sodium in vitro | Etalocib sodium formula | Etalocib sodium molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.